88 related articles for article (PubMed ID: 373190)
1. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
[TBL] [Abstract][Full Text] [Related]
2. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
[TBL] [Abstract][Full Text] [Related]
3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
5. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant assays of alloimmunity in predicting renal graft outcome.
Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR
Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029
[TBL] [Abstract][Full Text] [Related]
7. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
[TBL] [Abstract][Full Text] [Related]
8. The effect of peak and current serum panel-reactive antibody on graft survival.
Premasathian N; Panorchan K; Vongwiwatana A; Pornpong C; Agadmeck S; Vejbaesya S
Transplant Proc; 2008 Sep; 40(7):2200-1. PubMed ID: 18790191
[TBL] [Abstract][Full Text] [Related]
9. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
Dickmeiss E
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
[TBL] [Abstract][Full Text] [Related]
10. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
Dickmeiss E
Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
[TBL] [Abstract][Full Text] [Related]
11. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
Creemers P; Brink J; Kahn D
Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
[TBL] [Abstract][Full Text] [Related]
12. D lucus antigen defined lymphoblastoid cell panel allows detection of hitherto undetected adverse presensitization.
Suthanthiran M; Fotino M; Cheigh JS; Novogrodsky A; Rubin AL; Stenzel KH
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():199-202. PubMed ID: 386312
[No Abstract] [Full Text] [Related]
13. [ADCC against human class II antigens in renal transplantation].
Takeda Y
Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):246-54. PubMed ID: 2157948
[TBL] [Abstract][Full Text] [Related]
14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
15. Role of humoral presenitization in human renal transplant rejection.
Gailiunas P; Suthanthiran M; Busch GJ; Carpenter CB; Garovoy MR
Kidney Int; 1980 May; 17(5):638-46. PubMed ID: 6995691
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection.
Poggio ED; Augustine JJ; Clemente M; Danzig JM; Volokh N; Zand MS; Hricik DE; Heeger PS
Transplantation; 2007 Apr; 83(7):847-52. PubMed ID: 17460554
[TBL] [Abstract][Full Text] [Related]
17. Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.
Suthanthiran M; Fotino M; Gibofsky A; Cheigh JS; Stenzel KH; Rubin AL; Novogrodsky A
Transplant Proc; 1979 Jun; 11(2):1263-4. PubMed ID: 382502
[No Abstract] [Full Text] [Related]
18. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
[TBL] [Abstract][Full Text] [Related]
19. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
20. The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targets.
Nathan P; Plessinger RT; First MR
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():62-7. PubMed ID: 386322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
